2. DEFINITON
HCM is defined by the ↑↑ LV wall thickness ≥15 mm in one or
more LV myocardial segments.
measured by any imaging technique that is not solely explained
by abnormal loading conditions.
HCM is genetically determined heart muscle disease caused by mutations
in one of several sarcomere genes which encode components of the
contractile apparatus.
61. Makavos, G., Κairis, C., Tselegkidi, M. E., Karamitsos, T., Rigopoulos, A. G., Noutsias, M., &
Ikonomidis, I. (2019). Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis,
and treatment. Heart failure reviews, 1-21.
Wan, B., Rahnavardi, M., Tian, D. H., Phan, K., Munkholm-Larsen, S., Bannon, P. G., & Yan, T. D. (2013). A
meta-analysis of MitraClip system versus surgery for treatment of severe mitral regurgitation. Annals of
cardiothoracic surgery, 2(6), 683.
Mohr, F. W., Seeburger, J., & Misfeld, M. (2013). Keynote Lecture—Transmitral hypertrophic obstructive
cardiomyopathy (HOCM) repair. Annals of cardiothoracic surgery, 2(6), 729.
Yacoub, M. H., Afifi, A., Saad, H., Aguib, H., & ElGuindy, A. (2017). Current state of the art and future of
myectomy. Annals of cardiothoracic surgery, 6(4), 307.
Messmer, B. J. (2004). Extended myectomy for hypertrophic obstructive cardiomyopathy. Operative
Techniques in Thoracic and Cardiovascular Surgery, 9(4), 268-277.
Khouzam, R. N., & Naidu, S. S. (2014). Current status and future perspectives on alcohol septal ablation
for hypertrophic obstructive cardiomyopathy. Current cardiology reports, 16(5), 478.
Naidu, S. S. (Ed.). (2019). Hypertrophic Cardiomyopathy.
Nguyen, A., & Schaff, H. V. (2017). Transaortic septal myectomy for obstructive hypertrophic
cardiomyopathy. Operative Techniques in Thoracic and Cardiovascular Surgery, 22(4), 200-215.
References